AllianceBernstein
IMUX icon

AllianceBernstein’s Immunic IMUX Stock Holding History

AllianceBernstein’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-824
Closed -$91K – 3117
2018
Q3 		$91K Buy
+824
New +$2.15M ﹤0.01% 3090
2015
Q2 		– Sell
-11
Closed -$105K – 3146
2015
Q1 		$105K Buy
11
+5
+83% +$46K ﹤0.01% 3018
2014
Q4 		$55K Sell
6
-2
-25% -$15.4K ﹤0.01% 3090
2014
Q3 		$67K Hold
8
– – ﹤0.01% 3039
2014
Q2 		$90K Buy
+8
New +$56.1K ﹤0.01% 3016

Other funds holding IMUX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

AllianceBernstein's IMUX Position: Q4 2018 in Review

AllianceBernstein sold out of Immunic (IMUX) in Q4 2018, closing a stake of 824 shares — an estimated $91K sold.

AllianceBernstein first reported a position in IMUX in Q2 2014 and held it in 5 quarters. The position peaked at $105K in Q1 2015. 47 funds tracked by Wall St. Rank hold IMUX as of Q4 2018.

  • AllianceBernstein reported no remaining Immunic position as of Q4 2018 after selling out during the quarter.
  • AllianceBernstein sold 824 Immunic shares in Q4 2018, an estimated $91K.
  • AllianceBernstein first reported a position in Immunic in Q2 2014 and held it in 5 quarters.
  • AllianceBernstein's Immunic position peaked at $105K in Q1 2015.
  • 47 funds tracked by Wall St. Rank held Immunic as of Q4 2018.

Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.